Literature DB >> 12458105

Clinical evaluation of onset of analgesia using intravenous pamidronate in metastatic bone pain.

Eugen B Petcu, Stephan A Schug, H Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12458105     DOI： 10.1016/s0885-3924(02)00478-5

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN： 0885-3924            Impact factor:   3.612


× No keyword cloud information.
  6 in total

1.  Osteoimmunology at the nexus of arthritis, osteoporosis, cancer, and infection.

Authors:  Dallas Jones; Laurie H Glimcher; Antonios O Aliprantis
Journal:  J Clin Invest       Date:  2011-07-01       Impact factor: 14.808

Review 2.  Targeting the bone microenvironment in multiple myeloma.

Authors:  G David Roodman
Journal:  J Bone Miner Metab       Date:  2010-02-04       Impact factor: 2.626

Review 3.  Pamidronate treatment in rheumatology practice: a comprehensive review.

Authors:  Gleb Slobodin; Itzhak Rosner; Joy Feld; Doron Rimar; Michael Rozenbaum; Nina Boulman; Majed Odeh
Journal:  Clin Rheumatol       Date:  2009-08-19       Impact factor: 2.980

4.  Bisphosphonate-related osteonecrosis of jaw (BRONJ): an anti-angiogenic side-effect?

Authors:  Eugen B Petcu; Saso Ivanovski; Robert G Wright; Mark Slevin; Rodica I Miroiu; Klara Brinzaniuc
Journal:  Diagn Pathol       Date:  2012-07-06       Impact factor: 2.644

5.  The effect of bisphosphonates on the endothelial differentiation of mesenchymal stem cells.

Authors:  Dileep Sharma; Stephen Mark Hamlet; Eugen Bogdan Petcu; Saso Ivanovski
Journal:  Sci Rep       Date:  2016-02-09       Impact factor: 4.379

6.  Bisphosphonate-related osteonecrosis of jaw (BRONJ): diagnostic criteria and possible pathogenic mechanisms of an unexpected anti-angiogenic side effect.

Authors:  Dileep Sharma; Saso Ivanovski; Mark Slevin; Stephen Hamlet; Tudor S Pop; Klara Brinzaniuc; Eugen B Petcu; Rodica I Miroiu
Journal:  Vasc Cell       Date:  2013-01-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.